ROC curve analysis was conducted to compare CSF1R methylation levels in ANTs and HCC tissues and to verify whether the methylation level of the CSF1R promoter region could be used as a biomarker for HCC diagnosis and treatment (Fig. 3). This evidence concerns the gene CSF1R and hepatocellular carcinoma.